Management Team

Dr. Chia-Nan Chen

Chairman of the Board / President

In 2013, Dr. Chen was one of the founders of GNTbm and served as a board member and the President. Since 2016, he has served as the Chairman of the Board/President. Dr. Chen studied pharmacy, passed the national examination and is a pharmacist. He conducted further study and focused on research in the fields of chemistry, biochemistry, and molecular biology. He received his Ph.D. in Biochemistry and Molecular Biology in 2004 from the College of Medicine at National Taiwan University and then joined the National Health Research Institutes (NHRI, Taiwan) as a postdoctoral fellow. After his postdoctoral training, Dr. Chen moved into industry, where he served as the Vice President of Research and Development for NatureWise Biotech and Medicals Corporation, which is mainly engaged in the development of new drugs, and then as the Vice President and President in GNT Inc. Now, Dr. Chen is the Chairman of the Board and the President of GNTbm. Dr. Chen is devoted to the development of epigenetic modulators, tumor microenvironment regulators, epigenetic immunoactivators, and  immunoregulatory multi-kinase inhibitors in cancer immunotherapy field. He has applied for, and been awarded, invention patents overseas for more than 15 projects, and has published more than 20 scientific articles in international journals. Dr. Chen’s biggest passion is to develop new drugs to satisfy the unmet needs of advanced cancer patients.



Dr. Ye-Su Chao

Vice President

Dr. Ye-Su Chao has served as the Vice President of GNTbm since 2014; she assists mainly in business operations, business development, and R&D progress. Dr. Chao received her Ph.D. in Molecular Biology from the University of Southern California in 1992, specializing in gene expression and regulation. After graduation, Dr. Chao continued her postdoctoral research at the University of California, Berkeley, and at the University of California, San Francisco, from 1992 to 1997, focusing on gene regulation in plants and the HIV virus. From 1998 to 1999, as a research scientist, she studied gene regulation in breast cancer at the University of California, San Francisco. From 2000 to 2002, she was a researcher at the Industrial Technology Research Institute, and from 2002 to 2014, she worked for the Development Center for Biotechnology, once serving as the Director of the Technology Transfer Department and a Program Director, committed to the promotion of the development of biotechnology and pharmaceutical industries.


Dr. Jia-Shiong Chen

Director of the R&D Center

Since 2015, Dr. Jia-Shiong Chen has been the manager of R&D Center at GNTbm and is responsible mainly for R&D. Dr. Chen graduated from the Department of Pharmacology at National Yang-Ming University, where he specialized in research into the use of small molecule drugs in the treatment and prevention of cardiovascular diseases. He is experienced in anti-atherosclerosis research and vascular stem cell culture and its application in cell therapy, especially in animal models. Dr. Chen received his Ph.D. in 2011 and subsequently worked for the Institute of Clinical Medicine at the National Yang-Ming University as a postdoctoral fellow for four years, mainly focusing on the development of animal models of obesity, metabolic diseases, and cardiovascular diseases. Dr. Chen has published more than 31 scientific articles in international journals.